Protein Information

• ID:  hd00021
• Active Ingredients:  Abarelix
• DRUGBANK Accession Number:  DB00106 (BTD00051, BIOD00051)
• Active Sequence:  XXXSYNLXPA
• Sequence Length:  10
• Type:  Small Molecule
• Description:  Synthetic decapeptide antagonist to gonadotropin releasing hormone (GnRH). It is marketed by Praecis Pharmaceuticals as Plenaxis. Praecis announced in June 2006 that it was voluntarily withdrawing the drug from the market.
• Disease:  Prostate cancer
• CAS:  183552-38-7
• SMILES:  CC(C)CC(C(=O)NC(CCCCNC(C)C)C(=O)N1CCCC1C(=O)NC(C)C(=O)N)NC(=O)C(CC(=O)N)NC(=O)C(CC2=CC=C(C=C2)O)N(C)C(=O)C(CO)NC(=O)C(CC3=CN=CC=C3)NC(=O)C(CC4=CC=C(C=C4)Cl)NC(=O)C(CC5=CC6=CC=CC=C6C=C5)NC(=O)C